Colgate-Palmolive Company (NYSE:CL) posted better-than-expected second-quarter earnings on Friday.

Colgate-Palmolive reported second-quarter adjusted earnings per share of 92 cents, beating the analyst consensus estimate of 89 cents. Quarterly sales of $5.11 billion (+1% year over year) outpaced the Street view of $5.03 billion.

The company continues to expect net sales to increase in the low single digits, now factoring in a flat to low-single-digit negative impact from foreign exchange. Organic sales growth is projected to be at the low end of the 2% to 4% range, reflecting the planned exit from private label pet sales over the course of 2025.

On a non-GAAP (Base Business) basis, the company still anticipates gross profit margin and advertising to remain …

Full story available on Benzinga.com